Solesence Inc(SLSN)
Search documents
Solesence Inc(SLSN) - Prospectus
2023-11-21 22:25
Registration No. 333- As filed with the Securities and Exchange Commission on November 21, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NANOPHASE TECHNOLOGIES CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 3390 36-3687863 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 1319 ...
Solesence Inc(SLSN) - 2023 Q3 - Quarterly Report
2023-11-14 21:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _______ to _______ Commission File Number: 000-22333 Nanophase Technologies Corporation (Exact name of registrant as specified in its charter) (State or other ju ...
Solesence Inc(SLSN) - 2023 Q2 - Quarterly Report
2023-08-10 20:32
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _______ to _______ Commission File Number: 000-22333 Nanophase Technologies Corporation (Exact name of registrant as specified in its charter) (State or other jurisdi ...
Solesence Inc(SLSN) - 2023 Q1 - Quarterly Report
2023-05-12 20:12
Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _______ to _______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 1319 Marquette Drive, Romeoville, Illinois 60446 (Address of principal executive offices, and zip code) Registrant's telephone number, including a ...
Solesence Inc(SLSN) - 2022 Q4 - Annual Report
2023-03-29 20:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM_____ TO_____ COMMISSION FILE NUMBER 000-22333 NANOPHASE TECHNOLOGIES CORPORATION (Exact name of registrant as specified in its charter) of incorporation or organization) Dela ...